Current Opinion in Endocrinology and Diabetes was launched in 1994, with Obesity added to the title in 2007. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of endocrinology and diabetes are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce one of the Journal's Section Editors for this issue.
Peter A. Gottlieb
Dr Peter A. Gottlieb was born in Havana, Cuba, but at age 2 moved to New Jersey, USA, where he grew up. After receiving his undergraduate degree from the University of Pennsylvania, USA, he attended UMDNJ-Robert Wood Johnson Medical School, USA, from which he graduated in 1984. Dr Gottlieb completed his internship and residency in internal medicine at the University of Massachusetts Medical School, USA and then continued his fellowship training in endocrinology and metabolism there as well.
In 1990, after completing his fellowship, he moved to the Weizmann Institute in Israel to undertake post-doctoral training in T cell immunology. After surviving Gulf War I, he returned to UMass, USA, and joined the staff as Clinical Director of Diabetes. He subsequently joined the Barbara Davis Center for Childhood Diabetes, Aurora, USA, in 1995, where he is now a Professor of Pediatrics and Medicine and the Director of the Translational Research Unit at the Barbara Davis Center. He has authored, co-authored and collaborated on more than 140 publications, reviews, and book chapters, and served as section editor for several journal editions. His research areas of interest include the immunology of type 1 diabetes, intervention trials to prevent or reverse type 1 diabetes, and the genetics of autoimmune disease. He has led several multi-center trials in new onset type 1 diabetes and is an active member of the Steering Committee for Type 1 Diabetes TrialNet.
Whitney W. Woodmansee
Dr Whitney W. Woodmansee is Professor of Medicine in the Division of Endocrinology, Diabetes and Metabolism at the University of Florida in Gainesville, FL, USA. She is currently the Director of the UF Neuroendocrine and Thyroid Tumor Programs. Dr Woodmansee received her medical degree and completed her clinical training in internal medicine and endocrinology at the University of Colorado Health Sciences Center (UCHSC) in Denver, CO, USA. After completing her training, she joined the faculty at UCHSC in 1999 where she performed basic science research in the neuroendocrine field, as well as directed the Pituitary Disorders Program. In 2009, she was recruited as the Director of the Clinical Neuroendocrine Program at Brigham and Women's Hospital in Boston, MA and was on the faculty at Harvard Medical School. In this position, she had a very active clinical practice caring for patients with pituitary disorders and conducted clinical trials in the pituitary field. In 2018, Dr Woodmansee moved to the University of Florida where she will continue her patient care and clinical research work in pituitary disorders. She has a particular interest in the management of hypopituitarism.